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We explored the intra- and extracellular processes governing
the kinetics of extracellular ATP (ATPe) in human erythrocytes
stimulated with agents that increase cAMP. Using the luciferin-
luciferase reaction in off-line luminometry we found both direct
adenylyl cyclase activation by forskolin and indirect activation
through-adrenergic stimulationwith isoproterenol-enhanced
[ATP]e in a concentration-dependent manner. A mixture (3V)
containing a combination of these agents and the phosphodies-
terase inhibitor papaverine activated ATP release, leading to a
3-fold increase in [ATP]e, and caused increases in cAMP con-
centration (3-fold for forskolin  papaverine, and 10-fold for
3V). The pannexin 1 inhibitor carbenoxolone and a pannexin 1
blocking peptide (10Panx1) decreased [ATP]e by 75–84%. The
residual efflux of ATP resulted from unavoidable mechanical
perturbations stimulating a novel, carbenoxolone-insensitive
pathway. In real-time luminometry experiments using soluble
luciferase, addition of 3V led to an acute increase in [ATP]e to a
constant value of 1 pmol  (106 cells)1. A similar treatment
using a surface attached luciferase (proA-luc) triggered a rapid
accumulation of surface ATP levels to a peak concentration of
2.4 pmol (106 cells)1, followed by a slower exponential decay
(t1⁄2  3.7 min) to a constant value of 1.3 pmol  (106 cells)1.
Both for soluble luciferase and proA-luc, ATP efflux was fully
blocked by carbenoxolone, pointing to a 3V-induced mecha-
nism of ATP release mediated by pannexin 1. Ecto-ATPase
activity was extremely low (28 fmol  (106 cells min)1), but
nevertheless physiologically relevant considering the high den-
sity of erythrocytes in human blood.
All cell types appear to possess mechanisms that enable a
controlled, nonlytic release of ATP, that is, a release not involv-
ing cell membrane rupture, and which occurs in response to
osmotic, mechanical, and/or neurohormonal stimuli (1). Spe-
cifically human erythrocytes release ATP following exposure to
-adrenergic stimulation, mechanical deformation, reduced
oxygen tension, or acidosis (2). All of these represent physio-
logical conditions to which erythrocytes are exposed in the vas-
culature, e.g.when passing through constricted vessels or in the
contracting striated muscle (3). Once in the extracellular
medium, extracellular ATP (ATPe)5 can trigger different cellu-
lar responses by interacting with P receptors on the cell surface
while at the same time its concentration is controlled by the
activities of one or more ectonucleotidases (4, 5). Several
reports published over recent years have shown that an increase
in intracellular cyclic AMP (cAMP) concentration triggered
ATP release from human erythrocytes (6, 7). Receptor-medi-
ated ATP release in human erythrocytes involves activation of
heterotrimeric G proteins Gs or Gi/o (3, 8, 9). Regarding the Gs
pathway, activation of -adrenergic receptors by various ago-
nists was reported to stimulate adenylyl cyclase, with concom-
itant increases in cAMP levels and protein kinase A activity (6,
10). Moreover, direct activation of adenylyl cyclase by forskolin
resulted in bothATP release and cAMP increases in human and
rabbit erythrocytes (6).
Despite the accumulated knowledge regarding the intracel-
lular signaling eventsmediating ATP release, comparatively lit-
tle is known regarding the processes governing the kinetics of
ATPe accumulation at the surface in animal cells (11, 12), with
rates of intracellular ATP release and extracellular ATP hydro-
lysis being themain actors. The human non-nucleated erythro-
cyte is an excellent model in this respect, because it lacks intra-
cellular compartments and direct cell-cell communication that
would enhance the available signaling mechanisms inducing
ATP release, and therefore complicate the analysis of ATPe
homeostasis. Among potential candidate membrane-bound
proteins enabling a regulated nonlytic ATP efflux, pannexin 1
was identified as a molecule that might associate with the iono-
tropic P receptor P2X7, and probably other P receptors (13).
Pannexin 1 appears to either constitute a large pore by itself or
to be responsible for the activation of a large pore capable of
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carrying ions and signaling molecules between the cytoplasm
and extracellular space (14). As such, pannexin 1 is a candidate
ATP release channel in erythrocytes, because it is expressed at
high levels in these cells (15).
In the present study, we investigated the homeostasis of
ATPe from erythrocytes stimulated with agents that increase
intracellular cAMP.We focused our attention on the activation
of the Gs pathway by isoproterenol, a well known -adrenergic
agonist. Because of the relatively modest increases in cAMP
level and ATP release observed with this agonist, addition of
forskolin together with the phosphodiesterase inhibitor papav-
erine was used to enhance the dynamic range of the response.
We examined the role of pannexin 1 as a necessary mediator
of ATP exit in human erythrocytes. Moreover, by studying the
kinetics of ATP accumulation in the extracellular space and the
capacity of cells to hydrolyze ATPe by ecto-ATPase activity, we
were able to estimate, for the first time in human erythrocytes,
the precise kinetics of pannexin 1-mediated ATP release. This
allowed us to analyze the interplay between time-dependent
extracellular ATP consumption and the release of cytosolic
ATP. For a comparative purpose, critical experiments were
conducted with canine and Xenopus erythrocytes.
EXPERIMENTAL PROCEDURES
Reagents—All reagents used in this study were of analytical
grade. Isoproterenol, forskolin, papaverine, carbenoxolone,
cAMP, dibutyryl cyclic AMP, 2-O-monosuccinyladenosine-
3,5-cyclic monophosphate tyrosyl methyl ester (TME-
cAMP), ATP, chlorpromazine, and chloroacetaldehyde were
purchased from Sigma. Pannexin 1 blocking peptide WRQ-
AAFVDSY (10Panx1) (16), and its scrambled version (ScrPanx1)
SADYRVAFWQ, generated using the online software at Gen-
Script were synthesized at the University of North Carolina
Microprotein Sequencing and Peptide Synthesis Facility. The
BCECF-AMandHoechst 33258were obtained fromMolecular
Probes (Invitrogen). A monoclonal antibody against an extra-
cellular segment from glycophorin A was purchased from
Abcam (Cambridge, MA). [-32P]ATP (10 Ci mmol1) and
[-32P]ATP (30 Cimmol1) were purchased fromPerkinElmer
Life Sciences.
Isolation of Erythrocytes—Human blood was obtained by
venipuncture from healthy volunteers on the day each study
was done. Immediately after collection of blood, plasma, plate-
lets, and leukocytes were removed by centrifugation (900 g at
20 °C for 3min). The supernatant and buffy coat were removed
by aspiration and discarded. Isolated erythrocytes were resus-
pended and washed three times in RBCmedium containing (in
mM) 155 NaCl, 2.7 KCl, 1.5 KH2PO4, 2.5 Na2HPO4, 1 CaCl2, 1
MgSO4, 5 glucose (pH adjusted to 7.4 at 20 °C and osmolarity to
300 mosmol). Packed erythrocytes were resuspended in RBC
medium supplemented with 0.5% bovine serum albumin to the
corresponding final hematocrit. All procedures conformed to
the Declaration of Helsinki, and written informed consent was
given by the donors. In preliminary experiments aliquots of the
resulting erythrocyte suspensions were stained with the blue
fluorescent Hoechst dye to check for the presence of nucleated
cells. Results of these experiments showed only 0.05% contam-
ination of our preparation with nucleated cells. Xenopus laevis
erythrocytes were isolated as in humans. Canine erythrocytes
were obtained from blood samples as above using a modified
RBC medium without CaCl2.
In supplemental Fig. S4, a subpopulation of RBCs containing
only anucleated mature erythrocytes was used. Cells were iso-
lated by means of a discontinuous Percoll density gradient as
previously described (31).
Measurement of ATPe—Extracellular ATP was measured
using firefly luciferase (EC 1.13.12.7), which catalyzes the oxi-
dation of luciferin in the presence of ATP to produce light
(17, 18).
Two different types of determinations were made, real-time
and off-line luminometry. In most experiments soluble lucifer-
ase was used, whereas in a few real-time experiments determi-
nation of ATPe on the cell surface was estimated by a fusion
protein denoted as proA-luc. In all cases (real-time or off-line
luminometry, using luciferase or proA-luc) the same luciferase
reaction was used to estimate ATPe via quantification of light
emission.
Real-time luminometry measurements were performed with
cells on coverslips that weremounted in the assay chamber of a
custom-built luminometer as described earlier (19). Because
luciferase activity at 37 °C is only 10% of that observed at 20 °C
(20), tomaintain full luciferase activity real-timeATPmeasure-
ments were performed in a cool chamber acclimated at 20 °C.
Under the experimental conditions, assay volume did not
change during the course of the experiment. Measurements
were performed with 3  106 cells incubated in 40 l of RBC
medium. Under these conditions the medium has a height of
about 104 m (height at the coverslip bottom of the chamber
equals 0). The time course of light emission was transformed
into ATPe concentration versus time by means of a calibration
curve. Increasing concentrations of ATP from 0.25 to 2,500 nM
were sequentially added to the assaymedium from a stock solu-
tion of ATP dissolved in RBCmedium. Also, a calibration curve
was performed for each experiment in similar conditions but in
the absence of cells. Both calibration curves displayed a linear
relationship in the range tested. The slopes of these curves were
directly related to luciferase activity. To avoid errors in the cal-
culation of absolute ATPe values only the experiments with
similar parameter values of the calibration function with or
without cells were used. In preliminary experiments we found
no effect of 100 M carbenoxolone on luciferase activity.
In experiments of Fig. 5, detection of cell surface ATP was
performed using proA-luc, a fusion protein between staphylo-
coccal protein A and firefly luciferase (21). Protein A specifi-
cally binds to the Fc domain of immunoglobulinG (IgG) and, as
mentioned before, firefly luciferase can be used to detect ATP
by luminescence emission. ProA-luc can then be stably
adsorbed onto the surface of intact cells via interactions with
primary IgG antibodies directed against native surface antigens
(22). The spatial resolution of themethod enables the detection
of local changes on the surface of cells. For human erythrocytes
we used an antibody against the N-terminal extracellular seg-
ment of glycophorin A, the most abundant syaloglycoprotein
on human red cells (23).
In the cell-attached proA-luc assays, erythrocytes (3  106)
were attached on coverslips coated with 0.001% poly-D-lysine.
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At such a very low concentration of poly-D-lysine, negatively
charged human erythrocytes will adhere firmly and remain dis-
coidal in shape (24). Adherent cells on 25-mmdiameter circular
coverslips were washed twice with 150 l of RBC medium and
then allowed to incubate for 1 h in 40 l of RBC medium con-
taining the anti-glycophorin A antibody (1/250 dilution from
stock). Adherent cells were then washed three times and
allowed to incubate for another 1 h in 30 l of RBC medium
containing proA-luc (500 g/ml). Finally cells were washed
three times and incubated in 100 l of RBC medium until they
were used for real-time luminescence assays (as described
above for soluble luciferase). In preliminary experiments using
proA-luc, cells were challenged with exogenous ATP in the
presence of 150 M luciferin. Only those cells preincubated
with primary antibodies were able to emit detectable light,
demonstrating the specificity of proA-luc attachment to the
cell surface. Similarly, when monitoring endogenous ATPe
with proA-luc, no light was detected in experiments lacking the
primary antibody.
For the off-line luminometry human red blood cells were
incubated with different pharmacological agents. After the
incubation the erythrocyte suspensionwas centrifuged 2min at
1,000 g. ATPe levels were determined in 45l of the resulting
supernatant. A standard ATP curve was obtained for each
experiment. Although most experiments were conducted at
room temperature, to account for ATP release at a physiologi-
cal temperature the main off-line experiments were conducted
at both 20 and 37 °C.
Measurement of Intracellular ATP—For intracellular ATP
content estimations, erythrocytes (3  106) held on coverslips
were permeabilized with digitonin (50 g/ml) at the end of
real-time luminometry experiments. The released cytosolic
ATP was measured with luciferin-luciferase as described for
ATPe. After considering the total volume occupied by all eryth-
rocytes present in the chamber, and the relative solvent cell
volume, i.e. 70% (25), ATP values were expressed as the intra-
cellular ATP concentration of erythrocytes.
Purification of ProA-luc—A gene expression plasmid
pMALU7 was used that encodes the fused gene between pro-
tein A and the complete sequence of amutated firefly luciferase
(26).
Expression and purification methods were described before
(21, 22, 26). Briefly, the JM109 strain of Escherichia coli cells
was transformed with pMALU7. Transformed bacteria were
grown to mid-log phase at 37 °C at which time 1 mM isopropyl
-D-thiogalactopyranoside was added to induce protein ex-
pression. Bacteriawere harvested by centrifugation (4000 g at
4 ° for 4 min) and lysed by three cycles of sonication at 4 °C in
PBS medium containing 1 mM phenylmethylsulfonyl fluoride.
The bacterial lysate was centrifuged 7000  g (4 °C for 20 min)
and the supernatant was applied to a IgG-Sepharose affinity
column to collect the fusion protein. Fractions were eluted in
acetic acid buffer 0.5 M (pH 3.4) and allowed to drop directly
into a neutralization buffer (Tris chloride, 1 M, pH 8.0). Frac-
tions were tested for luciferase activity, and those containing
the peaks of the activity were pooled and concentrated 6-fold
using centrifugal filters (Centriprep, YM50, Millipore Corp.,
MA). Protein content was assessed by the method of Lowry et
al. (27).
Measurement of Intracellular Cyclic AMP—Human erythro-
cytes (50% hematocrit) were incubated 10min at room temper-
ature either in the absence (control) or presence of stimulating
agents. The reaction was stopped by the addition of 4 ml of
ice-cold ethanol containing HCl (1 mM) to the erythrocyte sus-
pension. The resulting erythrocyte/ethanolmixture was centri-
fuged at 14,000  g for 10 min at 4 °C. The supernatant was
removed and stored overnight at 20 °C to precipitate the
remaining proteins. Samples were then centrifuged a second
time at 3,700  g for 10 min at 4 °C. The supernatant was
removed and dried under vacuum centrifugation and the resi-
due was resuspended in 50 mM sodium acetate buffer (pH 6.0).
Unknown samples and standards were acetylated and mea-
sured by standard radioimmunoassay system using themethod
described by Steiner et al. (28) with modifications (29, 30). The
TME-cAMP was radiolabeled with Na125I by the method of
chloramine T (specific activity, 600 Ci/mmol) previously
described by Del Punta et al. (31). The specific antibody for
cAMP was provided by NIH (Dr. A. F. Parlow, National Hor-
mone and Peptide Program, NIDDK, National Institutes of
Health). The inter-assay and intra-assay variations of coeffi-
cients were lower than 10%.
Extracellular Hydrolysis of ATP, Adenosine Production, and
Ecto-ATPase Activity—The hydrolysis rate of ATPe was deter-
mined by following the accumulation of [-32P]Pi released from
exogenous [-32P]ATP added to a erythrocyte suspension of
known hematocrit, as described before (32–34) with modifica-
tions. Briefly, the reaction was started by adding 1 M
[-32P]ATP (0.27 Ci/mmol) to cell suspensions at room tem-
perature. At different times, a 200-l aliquot of the suspension
was withdrawn and centrifuged at 900  g during 30 s, and 100
l of the supernatant were poured into 750l of a stop solution
containing 4.05 mM Mo7O24(NH4)6 and 0.83 mM HClO4. The
ammonium molybdate solution formed a complex with the
released phosphate, which was then extracted by adding 0.6 ml
of isobutyl alcohol under vigorous stirring. After the phases
were separated by centrifugation for 5min at 1,000 g, aliquots
of 200 l of the organic phase containing [-32P]Pi were trans-
ferred to vials containing 2.5 ml of 0.5 M NaOH. Radioactivity
was measured by the Cerenkov effect. Production of adenosine
from ATP was estimated as described previously (33). The
release of-32Pi from [-32P]ATPwas followed using amethod
similar to that described for measuring ecto-ATPase activity.
Under these conditions, one adenosine is formed for every
-32Pi produced. Values of phosphate concentration in assay
medium lacking cells were used to estimate the phosphate con-
centration at time 0 of experiments run with cell suspensions.
Phosphate content in the absence of cells amounted to 1.5 
0.2% (n  3) of total ATP concentration in the assay medium,
anddid not increasewith time, i.e. the nonenzymatic phosphate
production was negligible.
Because erythrocyte uptake of ATP is extremely low, any
hydrolysis of [-32P]ATP into ADP [-32P]Pi in a cell suspen-
sion can be defined as ecto-ATPase activity, the time course of
which yields a measure of the rate at which ecto-nucleotidases
hydrolyze extracellular ATP. That is, whereas it is possible that
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more than one ecto-nucleotidase can contribute to the total
measured activity, the term ecto-ATPase has been used
because all ATPase activity measured in intact cell suspensions
resulted solely from the extracellular hydrolysis of the-Pi from
ATP. There may be more than one ENTPDase accounting for
ecto-ATPase activity, whereas no ecto-phosphatase activity
could be detected in human erythrocytes (35).
To calculate ecto-ATPase activity, time dependent levels of
Pi were fitted to Equation 1,
Y  Y0  A  1  e
 k  t	 (Eq. 1)
where Y and Y0 are the values of 32Pi at any time (t) and at t 0,
respectively;A represents the maximal value for the increase in
Ywith time, and k is a rate coefficient. The parameters of best fit
resulting from the regression were used to calculate the initial
rate of ecto-ATPase activity (vi) as kA (i.e. the first derivative of
Equation 1 for t tending to 0).
The 32Pi mass produced from [-32P]ATP and [-32P]ATP
was calculated using the ATP specific activity and expressed in
picomoles per 106 red blood cells. Ecto-ATPase activity is
expressed as picomoles of 32Pi  (106 cells min)1.
Cell VolumeDeterminations by FluorescenceMicroscopy—In
erythrocytes from several vertebrates species, adrenergic stim-
ulation can lead to cell swelling leading to changes in solute
intracellular content and activation of signaling mechanisms
(36). Therefore, we checked whether the potential volume
changes can affect cAMP concentration and/or the rate of ATP
release assessed in this study. To this end we monitored cell
volume of erythrocytes exposed to 3V, both in the presence and
absence of carbenoxolone. Relative cell volumes before and
after addition of pharmacological agents were estimated at
room temperature using the BCECF fluorescence quenching
method, as described (34, 37, 38). Under quenching conditions,
fluorescence intensity of human erythrocytes decreased with
the increase in fluorophore concentration. This property can be
used to continuously monitor changes in water cell volume
(34).
In brief, human erythrocytes (3  106 cells) were attached to
0.001% poly-D-lysine-coated coverslips. Erythrocytes were
incubated with RBC medium containing 5 m BCECF-AM
during 60min at room temperature. Subsequently, the solution
was washed with RBC medium for 30 min to eliminate extra-
cellular BCECF, and the coverslip was mounted on a recording
chamber in a Nikon TE-200 epifluorescence inverted micro-
scope. During experimental manipulations, all media were
removed from or introduced in the chamber manually.
Changes in cell water volume were inferred from readings of
fluorescence intensity recorded by exciting BCECF at 445 nm,
where the fluorochrome is pH-insensitive (34). Fluorescence
images were acquired by use of a charge-coupled device camera
(Hamamatsu C4742–95) and the Metafluor acquisition pro-
gram (Universal Imaging). Values of cell volume were obtained
from the fluorescence ratio (Ft/F0). The value of F0 represents
the signal obtained from a small circular digital region placed at
the image plane of each fluorophore-loaded cell equilibrated
with isotonic medium, whereas Ft denotes the fluorescence of
the same region of the cell at time t. Thus, this measure repre-
sents a fractional volume where the initial isotonic cell volume
value is 1 and volume changes are expressed as relative to the
initial value. A calibration is needed to convert values of relative
fluorescence for each cell to relative volume. Calibration was
performed by sequentially exposing cells to assay media of
osmolarities (in milliosmolar)  298, 285, 260, and 245. The
hypotonic media for cell volume calibrations was similar in
composition to isotonic RBC medium, except that the NaCl
concentration was adjusted appropriately. During all of these
sequential media exchanges, the X, Y, and Z positions of the
microscope field remained unchanged.
Hemolysis Measurements—Erythrocyte suspensions used to
measure extracellular ATP in off-line luminometry were cen-
trifuged at 1000  g for 2 min at room temperature. The
amount of hemoglobin present in the supernatant was deter-
mined bymeasurement of absorbance at 405 nm (oxyhemoglo-
bin). A calibration curve was obtained by measuring the
absorbance at 405 nm of a sequentially increasing known num-
ber of lysed erythrocytes. Experiments in which free hemoglo-
bin was detected were discarded to avoid the contribution of
ATPe content by hemolysis. For online measurements two
methods were used to assess time-dependent hemolysis.
First, fluorescence microscopy was used to measure hemo-
lysis as described earlier (8). Briefly, 3  106 erythrocytes were
loaded with BCECF and the retention of the intracellular fluo-
rophore was assessed before and after addition of pharmaco-
logical agents. A steep, acute loss of fluorophore was inter-
preted as cell death. Hemolysis was assessed each second
during 60 min and expressed as percentage.
Second, an enzymaticmethodwas used to detectmicroquan-
tities of free hemoglobin as described by Vazquez et al. (39).
Time-dependent hemolysis was measured before and after
addition of 3V, and expressed as percentage.
DataAnalysis—Statistical significancewas determined using
one-way analysis of variance followed by a Tukey-Kramer test
of multiple comparisons. A p value 	0.05 was considered sig-
nificant. In all of the experiments, numbers of determinations
(n) from independent preparations (N) are indicated.
RESULTS
Effect of Forskolin, Papaverin, and Isoproterenol on
Extracellular ATP Concentration from Human Erythrocytes
We first examined whether isoproterenol alone or in combi-
nation with agents that directly enhance cAMP concentration
were able to increase the concentration of [ATP]e.
Exposure of human erythrocytes to forskolin for 10 min
resulted in a dose-dependent enhancement of [ATP]e, with
nucleotide concentration being further increased when forsko-
lin was given together with 100 M of the phosphodiesterase
inhibitor papaverine (Fig. 1A). Similarly, the -adrenergic
receptor agonist isoproterenol (EC50  2.9 0.7 nM) promoted
an [ATP]e increase in a dose-dependent manner (Fig. 1B) that
was comparable in magnitude with that induced by forskolin.
The [ATP]e was enhanced 2-fold by 30 M forskolin and 100
Mpapaverine (from1.4 0.3 to 2.7 0.4 pmol (108 cells)1;
N  5, n  4; p 
 0.01) and 6-fold with an activating mixture
(called “3V”) containing 10 M isoproterenol, 30 M forskolin,
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and 100Mpapaverine (from1.4 0.3 to 8.5 0.4 pmol (108
cells)1; N  5, n  4; p 
 0.01; Fig. 1C).
Next, we checked whether these changes in [ATP]e corre-
lated with changes in intracellular cAMP concentration. As
shown in Fig. 1D, incubation of human RBC with 30 M
forskolin and 100 M papaverine resulted in a significant
increase in cAMP concentration at 10 min (from 0.027 
0.006 to 0.14  0.05 pmol  (109 cells)1;N  15, n  4,N 
10, and n  4, respectively; p 
 0.03). This effect was mark-
edly increased for 3V-exposed cells, i.e. when forskolin and
papaverin were added together with 10 M isoproterenol (from
0.14  0.05 to 0.32  0.04 pmol  (109 cells)1; N  10, n  4
and N  15, n  4, respectively; p 
 0.01). To further test the
correlation between increases in cAMP and ATPe, cells were
incubated with 1 mM of the cell-permeable cAMP analog dibu-
tyryl cyclic AMP, which induced an increase of [ATP]e from
1.6  0.3 pmoles  (108 cells)1 (N  3, n  2) to 3.7  0.4
pmoles  (108 cells)1 (N  3, n  2; p 
 0.01 (supplemental
Fig. S1).
Inhibition of Pannexin 1-mediated ATP Release from Human
Red Blood Cells
Pannexin 1 was suggested as one potential conduit for ATP
release of human erythrocytes (40, 41). Thus, we investigated
whether pharmacological inhibition of pannexin 1 by carben-
oxolone or by 10Panx1 can inhibit ATP release in our experi-
mental setup (Fig. 2).
The 3V stimulating mixture induced a significant increase in
[ATP]e compared with unstimulated cells (Fig. 2A, from 2.0 
0.1 to 8.6  0.4 pmol  (108 cells)1; N  4, n  4; p 
 0.01).
This effectwas reduced 78–84%bypreincubating the cellswith
either carbenoxolone at 10 M (Fig. 2A, 3.4  0.4 pmol  (108
cells)1; N  4, n  4; p 
 0.01) or 100 M (Fig. 2A, 3.1  0.8
pmol  (108 cells)1; N  4, n  4; p 
 0.01).
The 3V induced increase in [ATP]e was inhibited 75–80% by
30M 10Panx1 (from8.6 0.3 to 2.7 0.2 pmol (108 cells)1;
N 4,n 4;p
 0.02) although a significant 30% inhibitionwas
also observed with its scrambled control peptide (scrPanx1,
FIGURE 1. Isoproterenol-stimulated ATP release in human erythrocytes. A, human erythrocytes were incubated for 10 min with increasing concentrations
of forskolin in the presence (E) or absence (F) of the phosphodiesterase inhibitor 100 M papaverine, and extracellular ATP concentrations (ATPe) were
determined. Each point represents the mean  S.E. (error bars) of quadruplicate determinations from three independent experiments. B, human erythrocytes
were exposed to increasing concentrations of the -adrenergic receptor agonist isoproterenol and 100 M papaverine in the presence (E) or absence (F) of 30
M forskolin. Concentrations of ATPe were determined after 10 min of incubation at room temperature and expressed as percentage of the maximum ATPe
levels obtained. Data represent the mean  S.E. of quadruplicate assays from four independent experiments. C, extracellular ATP levels in human red blood
cells were determined under control conditions (Ctrl, empty bar) or in cells incubated for 10 min at room temperature with 100 M papaverine and 30 M
forskolin in the absence (Ctrl, right hatched bar) or presence (Iso, left hatched bar) of 10 M isoproterenol. Data represent mean  S.E. (error bars) of values of
quadruplicate determinations from five independent experiments (*, p 
 0.01 versus control). D, levels of cAMP human erythrocytes exposed to ATP release
stimulating agents. Cells were incubated for 10 min at room temperature under control conditions (Ctrl, empty bar), with 100 M papaverine and 30 M forskolin
in the absence (Ctrl, right hatched bar) or presence (Iso, left hatched bar) of 10 M isoproterenol. Data represent mean  S.E. of quadruplicate determinations
from 10 to 15 independent experiments (*, p 
 0.03, **, p 
 0.01 versus control). The concentration of ATPe was determined by off-line luminometry, whereas
that of cAMP by a radioimmunoassay (see “Experimental Procedures”).
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from 8.6  0.3 to 6.0  0.4 pmol  (108 cells)1; N  4, n  4;
p 
 0.05). Moreover, although the degree of [ATP]e inhibition
followed a function with 10Panx1 concentration, with [ATP]e
being 80% inhibited at 100 M 10Panx1, the scrambled peptide
also led to a significant concentration-dependent blockage of
ATPe release (see supplemental Fig. S5).
The above mentioned results were obtained by incubating
cells at room temperature; running experiments at 37 °C pro-
duced a similar trend. That is, under 3V exposure theATPewas
reduced 70% by 10 M carbenoxolone or 30 M 10Panx1,
whereas scrPanx1 produced a slight (10–15%) but not signifi-
cant inhibition (Fig. 2B).
Effect of Forskolin, Papaverine, and Isoproterenol on the
Concentrations of ATPe and cAMP from Xenopus and Canine
Erythrocytes
To test whether the above described dependence of ATP
release on cAMP is a common feature of other vertebrates, we
exposed nucleated erythrocytes from X. laevis to 3V stimula-
tion. Such a treatment produced a 15-fold increase in [ATP]e
over basal values (Fig. 3A), together with a 10-fold elevation of
intracellular concentrations of cAMP (Fig. 3B). Previously, it
was shown that dog RBC do not exhibit a pathway for cAMP-
dependent ATP release (6), so these cells can be used to test for
nonspecific effects of the agents used to enhance cAMP levels.
Following 3V activation of dog RBCs, there is a trend toward a
[cAMP] increase that is not statistically significant (from0.09
0.02 to 0.27 0.06 pmol (109 cells)1;N 4, n 4; p 0.07;
Fig. 3D), whereas no changes in [ATP]e are observed (Fig. 3C).
Kinetics of cAMP-stimulated ATP Release from Human and
Xenopus Erythrocytes
Up to here, determinations of accumulated ATPe by off-line
luminometry were performed at a fixed time point after stimu-
lation. However, to better understand the mechanism(s) allow-
ing a regulated ATP exit, we monitored the kinetics of [ATP]e
by real-time luminometry using either soluble luciferase or
proA-luc.
Real-time Measurement of [ATP]e Using Luciferase—In
human erythrocytes, a fast 2-fold increase of [ATP]e was
FIGURE 2. Inhibition of isoproterenol-induced ATP release from human red
blood cells. A, extracellular ATP levels (ATPe) were determined at 20 °C in
unstimulated cells (ctrl, empty bar), in cells stimulated 10 min with 3V alone (ctrl,
right fine hatched bar), or with 3V preceded by exposure to the following inhibi-
tors: carbenoxolone, 10 M (CBX 10, left fine hatched bar) or 100 (CBX 100, cross-
hatched bar), or 30 M pannexin 1-selective blocking peptide (10Panx1, right
coarse hatched bar) and 30 M scrambled control peptide (scrPanx1, left coarse
hatched bar). Data represent mean  S.E. of values of quadruplicate determina-
tions from four independent experiments (**, p 
0.01 versus control; ##, p 
0.05
versus 3V control). B, extracellular ATP levels (ATPe) were determined at 37 °C in
unstimulated cells (ctrl, empty bar), in cells stimulated 10 min with 3V alone (ctrl,
right fine hatched bar), or with 3V preceded by exposure to the following inhibi-
tors: 10 M carbenoxolone (CBX 10, left fine hatched bar), 30 M pannexin 1-selec-
tive blocking peptide (10Panx1, right coarse hatched bar), or the scrambled control
peptide (scrPanx1, left coarse hatched bar). Data represent mean  S.E. of quadru-
plicate determinations from three independent experiments (**, p 
 0.01 versus
control; #, p 
 0.01, and ##, p 
 0.02 versus 3V control).
FIGURE 3. Effect of isoproterenol on ATP release from Xenopus and dog
erythrocytes. A, [ATP]e of X. laevis erythrocytes incubated 10 min at room
temperature under unstimulated conditions (Ctrl, empty bar), with the ATP
stimulating mixture 3V (Ctrl, right hatched bar), or with 3V for cells pre-ex-
posed 5 min to 100 M carbenoxolone (CBX 100, left hatched bar). Data repre-
sent the mean  S.E. of quadruplicate assays from three independent exper-
iments (**, p 
 0.01 versus control; ##, p 
 0.01 versus 3V control). B, Xenopus
erythrocytes were incubated 10 min at room temperature under control con-
ditions (Ctrl, empty bar) or in the presence of 3V (hatched bar), and cAMP
concentrations were determined using a radioimmunoassay. Data represent
mean  S.E. of values of quadruplicate determinations from four indepen-
dent experiments (**, p 
 0.01 versus control). C, levels of ATPe in dog eryth-
rocytes determined under control conditions (empty bar) or in cells stimu-
lated for 10 min with 3V at room temperature (hatched bar). Data represent
mean  S.E. of quadruplicate determinations from three independent exper-
iments. D, cAMP levels for dog erythrocytes exposed 10 min at room temper-
ature under control conditions (empty bar) or in the presence of 3V (hatched
bar). Data represent mean  S.E. of quadruplicate determinations from three
independent experiments.
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observed after 3V stimulation, with [ATP]e reaching amaximal
value at 0.98 0.02 pmol (106 cells)1, which remained con-
stant thereafter (Fig. 4A). Addition of 100 M carbenoxolone
completely abolished ATP release (Fig. 4C). A similar kinetics
of [ATP]e was observed using a subpopulation of RBCs con-
taining only mature erythrocytes (supplemental Fig. S4).
InXenopus erythrocytes the kinetics of [ATP]e was different,
because following stimulation of ATP release a fast increase in
[ATP]e to amaximumvalue of 15.2 0.06 pmol (106 cells)1
was followed by a slow nonlinear decay with t1⁄2  7.5 0.6min
(Fig. 4B). As in human erythrocytes, 100 M carbenoxolone
completely abolished any [ATP]e increment (Fig. 4C).
To further validate the ATPe kinetics profile obtained, we
checked for artifacts created by potential alterations in hemo-
lysis and cell volume. Hemolysis could increase [ATP]e and
thus alter its accumulation profile, whereas changes in cell vol-
ume could modify the concentration of cAMP, and other sig-
naling molecules, and therefore indirectly affect ATP efflux.
This is why cell volume and hemolysis were determined con-
tinuously by fluorescencemicroscopy of BCECF-loaded human
erythrocytes. Results showed that 3V stimulation did not
change cell volume (supplemental Fig. S2). On the other hand,
hemolysis was assessed before and after exposure to 3V in the
absence or presence of carbenoxolone (CBX). After evaluating
3125 cells (n  5), we found only 6 hemolyzed erythrocytes
before application of the treatment (see supplementary Table
S1). If each hemolyzed erythrocyte would dilute instantly its
entire intracellular ATP content in the extracellular medium,
the measured [ATP]e (as shown in Fig. 4) would increase only
0.025%, i.e. a negligible contribution of cell death to [ATP]e. In
agreement with these calculations, hemolysis between 8 and 17
min of the basal trace (prior to stimulation) of Fig. 4A do not
cause any significant change in [ATP]e.
Parallel online experiments were run to assess hemolysis by
quantitating the amount of released hemoglobin (see “Experi-
mental Procedures”). In the absence of 3V (unstimulated con-
dition) a basal hemolysis of 0.16% was obtained (n  5).
Importantly, basal hemoglobin was content kept constant dur-
ing the treatment (from 338  80 to 320  117 ng/ml of hemo-
globin for untreated and 3V-treated cells, respectively; p 0.5),
so that 3V does not induce hemolysis.
Real-time Measurement of Surface ATP Using ProA-luc—
When cell-attached luciferase was used as the ATP sensor, 3V
activation triggered rapid accumulation of surface ATP levels
to a peak concentration of 2.4  1.13 pmol  (106 cells)1,
followed by a slower exponential decay (t1⁄2  3.7  1.0 min) to
a constant value of 1.3  0.05 pmol  (106 cells)1 (Fig. 5).
Similarly to real-time experiments with soluble luciferase, 100
M CBX fully blocks ATP release, so that no significant differ-
ences in surface ATP levels were detected using cells in control
medium, or inmedia with either CBXor 3V plus CBX (p 0.9).
The initial ATP release rate amounted to 2.6  1.4 pmol 
(106 cells min)1.
Metabolism of ATPe in Erythrocytes from Human, Xenopus,
and Dog
The observed kinetics of [ATP]e (Fig. 4) does not only
depend on the rate of ATP release, but also on the capacity of
ecto-nucleotidases to promote the extracellular hydrolysis
of ATP, i.e. ecto-ATPase activity. Thus, using suspensions of
human, Xenopus, and canine erythrocytes, at low and high
hematocrits, we determined the rate of ATP hydrolysis by fol-
lowing the time course of [-32P]Pi accumulation released from
1 M [-32P]ATP. Results were expressed as percentage of the
total ATP hydrolyzed at each time point (Fig. 6). Furthermore,
by calculating the initial rate values in each case we were able to
FIGURE 4. Kinetics of ATPe from cAMP-stimulated human and Xenopus
erythrocytes. A, time course of ATPe concentration ([ATP]e) from human
erythrocytes quantified by real-time luminometry. In the times indicated by
the arrow, cells were exposed to the 3V mixture (3V). Levels of ATPe are
expressed both as concentration (left axis) or as percentage of the intracellu-
lar ATP concentration (right axis). Data represent the mean from seven inde-
pendent preparations. B, kinetics of [ATP]e from X. laevis erythrocytes
exposed to 3V (3V arrow). Results represent the mean from six independent
preparations. C, [ATP]e kinetics from human and Xenopus erythrocytes prein-
cubated with 100 M carbenoxolone (CBX arrow), followed by addition of 3V
(3V arrow). Results represent the mean from six to seven independent prep-
arations, respectively.
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calculate ecto-ATPase activities (Fig. 7). As expected for
mature mammalian erythrocytes, in human and dog erythro-
cytes ecto-ATPase activities were very low (human, 0.028 
0.004 pmol of Pi (106 cellsmin)1; dog, 0.024 0.003 pmol of Pi
(106 cells min)1), whereas in Xenopus erythrocytes ecto-
ATPase activity assayed at the same ATP concentration was
about 45-fold higher than that in its mammalian counterparts
(1.2  0.2 pmol  (106 cells min)1; Fig. 7).
On the other hand, [-32P]ATP was used to monitor total
dephosphorylation of ATP to adenosine. Accordingly, addition
of [-32P]ATP to human erythrocyte suspensions resulted in
the release of [-32P]Pi at 0.014  0.003 pmol  (106 cells
min)1 (Fig. 6A). In the absence of cells, both the rates of
[-32P]Pi and [-32P]Pi release were negligible.
DISCUSSION
In humans, about 40% of blood is occupied by erythrocytes
containingmillimolar concentrations of ATP. Thus even a lim-
ited release ofATP from the large intracellular pool could result
in micromolar concentrations of ATPe under various physio-
logical conditions (42). Because specific P receptors forATP are
lacking on the erythrocytes plasma membrane (43, 44), the
resulting ATPe can thus primarily act on P2Y receptors of the
adjacent endothelial cells, or, in conjunction with ecto- and
exonucleotidase activities of the vasculature, ATPe can also
serve as a reservoir for the generation of the ADP or adenosine
agonists that subsequently target various functional P receptor
subtypes of erythrocytes (ADP-P2Y13 (43)/adenosine-A2B;
(34)) and endothelial cells (44–46). The physiological effects of
such ligand-receptor interactions can be manifold, including,
e.g. the alteration of the vascular tone (see discussion below).
Thus, in this study we analyzed the time dependent balance of
ATP efflux and ATPe hydrolysis to determine the factors gov-
erning the effective extracellular concentration of the nucleo-
tide, focusing on a condition when ATPe levels are elevated.
Specifically, we made use of the fact that over the past years a
growing body of evidence indicated that in human erythrocytes
an increase in cAMP elicited by various physiological stimuli
can induce a regulated release of ATP (8, 43, 47, 49, 50). The
kinetic properties of this ATP efflux has so far received little
attention and therefore, before studying the main features of
FIGURE 5. Detection of cell surface ATP in human erythrocytes. Cell sur-
face ATP determination was obtained using proA-luc and an antibody against
the N-terminal extracellular segment of glycophorin A in human erythrocytes
(). At the time indicated by the arrow, cells were exposed to 3V. Results
represent the mean from five independent preparations. For a comparative
purpose the time course of [ATP]e from human erythrocytes quantified with
soluble luciferase is shown (E).
FIGURE 6. Extracellular ATP hydrolysis in human, Xenopus, and dog erythro-
cytes. Time dependent changes in the concentration of extracellular ATP
([ATP]e) were determined by following the release of 32Pi from [-
32P]ATP or from
[-32P]ATP, as described under “Experimental Procedures.” A, in human erythro-
cytes, release of [-32P]Pi was assayed at hematocrits 1 (F) or 20% (E), and aden-
osine production (i.e. release of [-32P]Pi) was estimated at 20% hematocrit ().
B, release of [-32P]Pi in X. laevis erythrocytes was assayed at hematocrits 1 (F) or
6.5% (E); C, release of [-32P]Pi in dog erythrocytes was assayed at hematocrits 1
(F) and 20% (E). In all cases, results are expressed as percentage of the total
[-32P]ATP or [-32P]ATP hydrolyzed and represent mean  S.E. of quadruplicate
assays from at least two independent preparations. The continuous lines repre-
sent the best fit function to experimental data. As explained under “Experimental
Procedures,” the fitting procedure allowed calculating initial velocities for ecto-
ATPase activities of erythrocytes from human, dog, and Xenopus and adenosine
production from human erythrocytes. Accumulation of [-32P]Pi or [-
32P]Pi in
the absence of cells was negligible.
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ATP efflux in human erythrocytes, we established the optimal
conditions leading to a cAMP-dependent release of ATP. It has
been found that exposure to forskolin, to directly activate adenylyl
cyclase, to forskolin with papaverine, to simultaneously inhibiting
cAMP degradation, or -adrenergic stimulation with isoprotere-
nol, resulted in a dose-dependent increase in [ATP]e. This
increase in [ATP]e was potentiated when cells were exposed to a
combination of isoproterenol, forskolin, and papaverine (6-fold).
Because similar treatments produced significant increases in
cAMP of 3- (for forskolin papaverine) and 10-fold (for 3Vmix-
ture), a causal relationship linking increases in the concentrations
of cAMP and [ATP]e is clearly indicated.
An important aspect of this study addressed the nature of the
mechanism(s) leading to ATP release. Because mature mam-
malian erythrocytes lack vesicles and thus the capability to exo-
cytose ATP, and because the negatively charged ATP is imper-
meant for the phospholipidic plasma membrane, it has been
previously hypothesized that cAMP stimulated a conductive
mechanism of ATP exit (6). Among various other potential
transport proteins mediating such a conductive release, pan-
nexin 1 has been suggested to function as a nonselective chan-
nel to molecules of Mr less than 900 (40), so that it could also
transport ATP (Mr of ATP 507). Assuming an ATP electro-
chemical gradient of the order of 3–4 across the plasma mem-
brane, even brief activation of a nucleotide-permeable trans-
port would rapidly increase the rate of ATP delivery to the cell
surface (51) where it can be continuously detected by real-time
luminometry. Recently, Sridharan et al. (41) demonstrated that
treating human erythrocytes with three pannexin 1 inhibitors
prevented hypoxia-induced exit of the nucleotide. Moreover,
pannexin 1 is expressed at high levels in human erythrocytes,
where large conductance consistent with the properties of pan-
nexin 1 channel activity were observed (52). Accordingly, when
in the present study ATP release was induced by the activating
mixture 3V, carbenoxolone (a nonselective inhibitor of pannex-
ins and connexins) decreased [ATP]e by 75–84%both at 20 and
37 °C. The specific blocking of pannexin 1 by the peptide
10Panx1 also led to significant blockage of 3V-induced increases
in [ATP]e at 20 and 37 °C, but the fact that a scrambled peptide
used as a control also inhibited ATPe release precluded any
further use of 10Panx1. Noteworthy, this unspecific effect of
pannexin 1 mimetic peptides has been observed before, and is
in agreement with a steric effect on the channel rather than a
sequence specific action (53). In addition to the efflux pathway
as such, we wanted to characterize the main factors affecting
[ATP]e kinetics, so as to fully appreciate the homeostatic con-
trol of ATPe of human red blood cells.
In real-time measurements, soluble luciferase was used in a
small volume (40 l) of a relatively wide chamber, resulting in a
medium height of about 100 m, so that under this condition
luciferase acts as an indicator of bulk ATP levels within an
extracellular microenvironment of cells, whereas proA-luc
adsorbed to the extracellular domain of a membrane-bound
protein (in our case, glycophorin A) was used to detect ATP
levels at the cell surface.
Using soluble luciferase aswell as proA-luc, we observed that in
unstimulatedconditions, the steady level of [ATP]e (0 to10min) is
compatiblewitha lowecto-ATPaseactivitybeingatbalancewitha
basal rate of ATP release of the same magnitude (Figs. 4 and 5).
Following 3V exposure, accumulation ofATPwithin the extracel-
lular compartment will in principle reflect both an increase in the
rate of ATP release (by lytic and/or nonlyticmechanisms) and the
rate of ATP hydrolysis by membrane-bound ecto-nucleotidases.
However, in human erythrocytes the observed kinetics of [ATP]e
will primarily reflect the kinetics of ATP release, with little contri-
bution from other processes. This conclusion is suggested by the
following observations.
By continuously monitoring human erythrocytes we detected
virtually no hemolysis during the experiments (see supplemental
Table S1) that would enhance [ATP]e. Ecto-ATPase activity, an
ATPe remover at the cell surface, is extremely low. The latter is a
common feature of most anucleated mammalian erythrocytes as
can also be seen for dog erythrocytes (Fig. 7), whereas nucleated
erythrocytes from non-mammalian vertebrates, including Xeno-
pus erythrocytes (Fig. 7), display considerably higher rates of ATP
hydrolysis at the cell surface (54). The fact that, at least under the
conditions prevailing in our real-time experiments, the resulting
[ATP]e kinetics of human erythrocytes thus directly relates to the
kineticsofATPeffluxalloweda furtheranalysisof thekinetic char-
acteristics of ATP efflux.
Accordingly using soluble luciferase, addition of 3V led to a
steep, fast increase in [ATP]e to a steady value at about 1
pmol  (106 cells)1, which corresponded to an initial ATP
release rate of880 fmol (106 cellsmin)1, followed by rapid
flux inactivation. Interestingly, the acute increase of such a
potential extracellular signaling factor does not impose any
energetic burden on cells, because it requires less than 0.5% of
the available cytosolic ATP (Fig. 4A).
On the other hand, when the surface-attached proA-lucATP
sensor was used, exposure to 3V led to a steep increase of sur-
face [ATP]e to a maximum value, followed by a slower nonlin-
ear decay to a constant value. The calculated initial rate of ATP
release amounted to 2.6 pmol  (106 cells min)1, and com-
pares well with the 5 pmol  (106 cells min)1 obtained in
human astrocytoma cells using a similar proA-luc probe (51).
A comparison of [ATP]e kinetics from human erythrocytes
using luciferase and proA-luc is interesting because, as men-
tioned before, soluble luciferase dissolved in a very small assay
FIGURE 7. Ecto-ATPase activities of human, Xenopus, and dog erythrocytes.
Ecto-ATPase activities were determined from initial rate values of the 32Pi accu-
mulation profiles shown in Fig. 5. Erythrocyte suspensions from human (H, empty
bar),Xenopus (X, right hatched bar),anddog(D, left hatched bar)wereused.Results
are expressed as mean  S.E. of quadruplicate assays from at least five indepen-
dent experiments (**, p 
 0.01 versus human erythrocytes).
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volume would sense the immediate microenvironment of cells,
whereas proA-luc would sense the cell surface nanoenviron-
ment. As seen in Fig. 5, following 3V activation of human eryth-
rocytes, surface ATP showed a peak [ATP]e, which slowly
decreases to a constant value. A fit of an exponential function to
this decaying phase shows that ATPe would tend to stabilize at
a value that is slightly higher than but nevertheless close to the
constant maximal value of ATPe obtained with soluble lucifer-
ase. Unlike in most other cell systems, this slow nonlinear
[ATP]e decrease cannot be due to ecto-ATPase activity, which
we showed is negligible under the assay conditions. Thus, we
hypothesized that the observed ATPe decrease is due to extra-
cellular diffusion from cell surface into the bulk medium.
Regarding the differences in ATPe kinetics using both lucif-
erase probes, it is worth noting that human erythrocytes have a
net negative surface charge mainly due to ionized sialic acid
(55), and that at physiological extracellular pH most ATP mol-
ecules exist in anionic form (56). Thus, it is possible that the
kinetic profile of surface ATP can be modulated by this nega-
tively charged surface of human erythrocytes. In the absence of
experimental evidence, this statement remains speculative.
The fact that in human andXenopus erythrocytes, the 3V-in-
duced increase in [ATP]e was fully blocked by carbenoxolone
(Fig. 3A), implies that, at least under the experimental condi-
tions used here, pannexin 1 might act as the single conduit for
cAMP-induced ATP release of these cells. However, in off-line
experiments using human erythrocytes carbenoxolone only
inhibited 75–84% of the [ATP]e increase, pointing to an
additional, pannexin 1-independent mechanism of ATP
release. This discrepancy could be explained by assuming that
during the off-line experiments, cells held in suspension are
subjected to mechanical perturbations due to shaking upon
drug addition, whereas in real-time experiments cells are held
relatively unperturbed on the bottom of a chamber and mod-
ulators are added by diffusion (i.e. the medium is not
replaced). Accordingly, when in a new set of real-time exper-
iments a gentle mechanical perturbation was introduced (to
mimic the off-line condition) prior to 3V stimulation, a car-
benoxolone-insensitive component was detected (see sup-
plemental Fig. S3). This component proved to be induced by
mechanical perturbation not directly associated with the
cAMP-signaling cascade under study.
In Xenopus erythrocytes, the higher ATPe hydrolysis rate
agrees well with 3V activation curves where [ATP]e decreased
exponentially after a maximum (Fig. 4B). As in human erythro-
cytes, this [ATP]e kinetics agrees well with transient opening of
the ATP efflux through a pannexin 1-mediated pathway during
activation, suggesting that the observed release mechanism is a
conserved pathway among different vertebrates.
Regarding cellular and systemic roles of ATPe, the quantita-
tive ATPe profile described in this study for human erythro-
cytes is compatible with an in vivo scenario where, under
unstimulated conditions, [ATP]e is maintained constant at a
relatively low value (57), and acute increases occur only tran-
siently and in response to certain physiological and/or patho-
logical conditions. Assuming a 30–40% hematocrit in vivo and
a linear relationship between [ATP]e and hematocrit, activa-
tion of the cAMP pathway in circulating erythrocytes would
generate up to 1 MATPe, a concentration suitable for activat-
ing most P2 receptors in erythrocytes as well as in endothelial
cells (44, 45, 58). This is important inasmuch as activation of
P2Y1 and P2Y2 receptors in endothelial cells induces the gen-
eration and release of nitric oxide (59, 60), followed by relax-
ation of smooth muscles surrounding the capillaries of the
microcirculation (3) and a corresponding relaxation of vascular
tone. In the context of Fig. 5, the proA-luc ATP kinetics would
show the time-dependent changes of surface ATP that can be
used autocrinally for signaling. Soluble luciferase, on the other
hand, would show the ATPe kinetics of the microenvironment
(up to 100 m) that can be used for paracrine signaling.
To the present, the role of red blood cells in promoting the
hydrolysis of ATPe in blood has been neglected. However, the
mentioned high density of erythrocytes in blood implied that
the ecto-ATPase activity, even if extremely low compared with
erythrocytes of non-mammalian vertebrates (49), can contrib-
ute significantly to the hydrolysis of micro- and submicromolar
concentrations of ATPe. Moreover, as seen in Fig. 6A, human
erythrocytes are also capable of completely dephosphorylating
ATP to adenosine. This is compatible with the existence of an
enzymatic cascade involving ecto-nucleoside triphosphate
diphosphohydrolases (E-NTPDases) and ecto-5-nucleotidase
(5, 33), so as to sequentially hydrolyze ATP, ADP, and AMP.
Similarly to ATPe, the resulting extracellular adenosine may
interact with A2 receptors of the endothelium to also mediate
vasorelaxant effects (44). Thus, even if leukocytes and endothe-
lial cells, as well as plasma exonucleotidases exhibit various
degrees of ATP diphosphohydrolase activity (48, 61) the con-
tribution of erythrocytes to ATPe hydrolysis in blood cannot be
neglected, and should be taken into account for physiological
interpretations of ATPe actions within the vascular system.
In summary, we have shown that agents that induce intracel-
lular cAMP formation lead to a regulated release of ATP from
human erythrocytes, with Xenopus erythrocytes displaying a
qualitative similar pattern. Furthermore, our results are con-
sistent with pannexin 1 acting as a pore permeable to ATP or
being an essential mediator of cytoplasmic ATP exit. We show
here, for the first time, the transient nature of pannexin 1-me-
diated ATP efflux of human erythrocytes, where cAMP
increases lead to a steep activation that is rapidly inactivated. As
a corollary from this study it became apparent that caution
should be given to experiments where the effect of specific
stimuli is analyzed in cells suspensions, because besides pan-
nexin 1-mediated efflux, ATP can also be released via a carbon-
exolone-insensitive, mechanosensitive component.
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35. Lüthje, J., and Ogilvie, A. (1988) Eur. J. Biochem. 173, 241–245
36. Lecklin, T., Tuominen, A., and Nikinmaa, M. (2000) J. Exp. Biol. 203,
3025–3031
37. Hamann, S., Kiilgaard, J. F., Litman, T., Alvarez-Leefmans, F. J., Winther,
B. R., and Zeuthen, T. (2002) J. Fluoresc. 12, 139–145
38. Pafundo, D. E., Chara, O., Faillace, M. P., Krumschnabel, G., and Schwar-
zbaum, P. J. (2008) Am. J. Physiol. Regul. Integr. Comp. Physiol. 294,
R220–233
39. Vázquez, A., Tudela, J., Varón, R., and García-Cánovas, F. (1991)
J. Biochem. Biophys. Meth. 23, 45–52
40. Locovei, S., Wang, J., and Dahl, G. (2006) FEBS Lett. 580, 239–244
41. Sridharan, M., Adderley, S. P., Bowles, E. A., Egan, T. M., Stephenson,
A. H., Ellsworth,M. L., and Sprague, R. S. (2010)Am. J. Physiol. Heart Circ.
Physiol. 299, H1146–1152
42. Gorman,M.W., Feigl, E. O., and Buffington, C.W. (2007)Clin. Chem. 53,
318–325
43. Wang, L., Olivecrona, G., Götberg, M., Olsson, M. L., Winzell, M. S., and
Erlinge, D. (2005) Circ. Res. 96, 189–196
44. Erlinge, D., and Burnstock, G. (2008) Purinergic Signal. 4, 1–20
45. Kunapuli, S. P., and Daniel, J. L. (1998) Biochem. J. 336, 513–523
46. Burnstock, G. (2008) Pharmacol. Rep. 60, 12–20
47. Olearczyk, J. J., Stephenson, A. H., Lonigro, A. J., and Sprague, R. S. (2001)
Med. Sci. Monit. 7, 669–674
48. Koziak, K., Sévigny, J., Robson, S. C., Siegel, J. B., and Kaczmarek, E. (1999)
Thromb. Haemost. 82, 1538–1544
49. Misiti, F., Orsini, F., Clementi, M. E., Masala, D., Tellone, E., Galtieri, A.,
and Giardina, B. (2008) Biochem. Cell Biol. 86, 501–508
50. Sprague, R. S., Bowles, E. A., Hanson, M. S., DuFaux, E. A., Sridharan, M.,
Adderley, S., Ellsworth, M. L., and Stephenson, A. H. (2008) Microcircu-
lation 15, 461–471
51. Joseph, S. M., Buchakjian, M. R., and Dubyak, G. R. (2003) J. Biol. Chem.
278, 23331–23342
52. Locovei, S., Bao, L., and Dahl, G. (2006) Proc. Natl. Acad. Sci. U.S.A. 103,
7655–7659
53. Wang, J., Ma, M., Locovei, S., Keane, R. W., and Dahl, G. (2007) Am. J.
Physiol. Cell Physiol. 293, C1112–1119
54. Bencic, D. C., Yates, T. J., and Ingermann, R. L. (1997) Physiol. Zool. 70,
621–630
55. Eylar, E. H., Madoff, M. A., Brody, O. V., and Oncley, J. L. (1962) J. Biol.
Chem. 237, 1992–2000
56. Smith, R. M., Martell, A. E., and Chen, Y. (1991) Pure Appl. Chem. 63,
1015–1080
57. Coade, S. B., and Pearson, J. D. (1989) Circ. Res. 65, 531–537
58. Pirotton, S., Communi, D., Motte, S., Janssens, R., and Boeynaems, J. M.
(1996) J. Auton. Pharmacol. 16, 353–356
59. Jensen, F. B. (2009) J. Exp. Biol. 212, 3387–3393
60. Ellsworth, M. L., Ellis, C. G., Goldman, D., Stephenson, A. H., Dietrich,
H. H., and Sprague, R. S. (2009) Physiology 24, 107–116
61. Sévigny, J., Levesque, F. P., Grondin, G., and Beaudoin, A. R. (1997)
Biochim. Biophys. Acta 1334, 73–88
Homeostasis of ATPe in Human Erythrocytes
NOVEMBER 4, 2011 • VOLUME 286 • NUMBER 44 JOURNAL OF BIOLOGICAL CHEMISTRY 38407
